The new HER2DX central nervous system (CNS) progression score predicts risk of brain progression in advanced HER2+ breast cancer, addressing a major unmet need in identifying patients at the highest ...

Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

It’s a move that could alter care for millions of women and significantly affect those across the Brazos Valley, especially ...

Doctors have documented a rare case of a health worker catching H3N2 flu and then COVID-19 11 days later, just as H3N2 ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test Utilizing ...

Women at average risk for cervical cancer can avoid unpleasant tests in doctors' offices and instead safely test themselves at home for the virus that causes nearly all cases of the disease, the ...

SEOUL, South Korea, Dec. 5, 2025 /PRNewswire/ -- Seegene, Inc., a global leader in molecular diagnostics (MDx), announced today the establishment of a new subsidiary in France to reinforce its ...

Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using ...